Eli Lilly & Co. (LLY)
1417.54
+43.84
(+3.19%)
USD |
NYSE |
Oct 30, 16:00
1418.10
+0.56
(+0.04%)
Pre-Market: 20:00
Eli Lilly 30-Day Average Daily Volume : 2.448M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 2.448M |
| October 29, 2026 | 2.424M |
| October 28, 2026 | 2.342M |
| October 27, 2026 | 2.322M |
| October 26, 2026 | 2.324M |
| October 23, 2026 | 2.324M |
| October 22, 2026 | 2.310M |
| October 21, 2026 | 2.288M |
| October 20, 2026 | 2.293M |
| October 19, 2026 | 2.274M |
| October 16, 2026 | 2.283M |
| October 15, 2026 | 2.288M |
| October 14, 2026 | 2.244M |
| October 13, 2026 | 2.223M |
| October 12, 2026 | 2.263M |
| October 09, 2026 | 2.303M |
| October 08, 2026 | 2.348M |
| October 07, 2026 | 2.345M |
| October 06, 2026 | 2.339M |
| October 05, 2026 | 2.324M |
| October 02, 2026 | 2.341M |
| October 01, 2026 | 2.360M |
| September 30, 2026 | 2.439M |
| September 29, 2026 | 2.409M |
| September 28, 2026 | 2.414M |
| Date | Value |
|---|---|
| September 25, 2026 | 2.424M |
| September 24, 2026 | 2.424M |
| September 23, 2026 | 2.408M |
| September 22, 2026 | 2.407M |
| September 21, 2026 | 2.425M |
| September 18, 2026 | 2.439M |
| September 17, 2026 | 2.402M |
| September 16, 2026 | 2.553M |
| September 15, 2026 | 2.641M |
| September 14, 2026 | 2.676M |
| September 11, 2026 | 2.701M |
| September 10, 2026 | 2.740M |
| September 09, 2026 | 2.746M |
| September 08, 2026 | 2.757M |
| September 04, 2026 | 2.730M |
| September 03, 2026 | 2.723M |
| September 02, 2026 | 2.701M |
| September 01, 2026 | 2.671M |
| August 31, 2026 | 2.657M |
| August 28, 2026 | 2.643M |
| August 27, 2026 | 2.653M |
| August 26, 2026 | 2.655M |
| August 25, 2026 | 2.640M |
| August 24, 2026 | 2.657M |
| August 21, 2026 | 2.670M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Johnson & Johnson | 7.270M |
| Merck & Co., Inc. | 9.901M |
| Pfizer Inc. | 30.18M |
| Bristol Myers Squibb Co. | 12.72M |
| Structure Therapeutics, Inc. | 1.298M |